Drugs / ABMD-MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01686139 | Mar 2016 → Mar 2017 | type 1 diabetes mellitus, type 2 diabetes mellitus | Sheba Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABMD-MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01686139 ↗ |
| Modality | Cell therapy | “cultured Bone Marrow Mesenchymal Stromal Cells (BM-MSCs) from allogeneic donors” NCT01686139 ↗ |
| Route | Other | “The patient will receive multiple injections in one session during the study.” NCT01686139 ↗ |